South Korea Sets 2027 Medical School Quotas to Ease Regional Doctor Shortages
The South Korean government on Friday released its 2027 admission quotas for one of the country’s key medical training paths. Nationwide, excluding Seoul, 32 medical schools will enroll 3,548 students, up 490 from the 2024 level.
Regionally, the Busan–Ulsan–Gyeongnam area saw the largest planned increase, with six universities adding a total of 97 seats. However, Ulsan National University’s medical school added only five seats, lifting its intake from 40 to 45 for 2027, with a further increase to 46 planned from 2028.
Education officials noted that private universities in regions with base quotas under 50 can raise admissions by up to 12 seats, but Ulsan University’s gain falls short of half that potential. Analysts pointed to structural factors, such as the fact that the medical school and teaching hospitals are not all located in Ulsan, as a reason for the smaller increase.
Ulsan University acknowledged the government’s decision but did not indicate it would contest it, emphasizing that the allocation aligns with the institution’s educational infrastructure and capacity.
The added spots are tied to South Korea’s regional medical obligation policy. Under this framework, graduates must work for ten years in regional public medical facilities after graduation, and the government provides support for tuition and related costs.
The Ministry of Education plans to finalize the overall quotas after reviewing university appeals next month, meaning the numbers could still change before the new academic year.
Why this matters for the United States: Korea’s approach aims to address regional doctor shortages and ensure a distributed healthcare workforce, a concern that affects health policy, healthcare markets, and potential collaboration in medical research and education with U.S. institutions. As a global tech‑and‑biomedicine hub, Korea’s medical training pipeline can influence cross-border partnerships, clinical research, and the broader supply chain for medical services and devices in the Asia-Pacific region.